Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Tuesday, November 16, 2021, at 2 p.m. CET / 8 a.m. ET, to give an update on business progress during the third quarter of 2021.
Participating in the call will be Innate’s Chief Executive Officer Mondher Mahjoubi, MD and Chief Medical Officer Joyson Karakunnel, MD, MSc, FACP.
Details for the Virtual Event
The live webcast will be available at the following link:
Participants may also join via telephone using the following dial in numbers:
- France: +33 8056 20 704
- United States: +1 646 904 5544
- All other locations: +1 929 526 1599
- Access code: 043615
This information can also be found on the investors section of the Innate website, www.innate-pharma.com. A replay of the webcast will be available on the Company website following the event.